November 14, 2017 / 1:44 PM / in 10 days

BRIEF-Locus Biosciences closes $19 mln series A funding

Nov 14 (Reuters) - Locus Biosciences Inc

* Locus Biosciences closes $19 million series A led by Artis Ventures for CRISPR-Cas3 antimicrobials

* Locus Biosciences - closed $19 million series A funding, led by Artis Ventures with additional financing from Tencent Holdings & others Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below